Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 268

1.

Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.

Lerut J, Iesari S, Vandeplas G, Fabbrizio T, Ackenine K, Núñez MEI, Komuta M, Coubeau L, Ciccarelli O, Bonaccorsi-Riani E.

Hepatobiliary Pancreat Dis Int. 2019 Aug 25. pii: S1499-3872(19)30177-8. doi: 10.1016/j.hbpd.2019.08.005. [Epub ahead of print]

PMID:
31521538
2.

Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.

Moccia M, Prados F, Filippi M, Rocca MA, Valsasina P, Brownlee WJ, Zecca C, Gallo A, Rovira A, Gass A, Palace J, Lukas C, Vrenken H, Ourselin S, Gandini Wheeler-Kingshott CAM, Ciccarelli O, Barkhof F; MAGNIMS Study Group.

Ann Neurol. 2019 Aug 6. doi: 10.1002/ana.25571. [Epub ahead of print]

PMID:
31385358
3.

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.

Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O.

Brain. 2019 Aug 1;142(8):2276-2287. doi: 10.1093/brain/awz156.

PMID:
31342055
4.

Erratum: Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis.

Kanber B, Nachev P, Barkhof F, Calvi A, Cardoso J, Cortese R, Prados F, Sudre CH, Tur C, Ourselin S, Ciccarelli O.

NPJ Digit Med. 2019 Jul 16;2:66. doi: 10.1038/s41746-019-0144-7. eCollection 2019.

5.

Single-subject structural cortical networks in clinically isolated syndrome.

Collorone S, Prados F, Hagens MH, Tur C, Kanber B, Sudre CH, Lukas C, Gasperini C, Oreja-Guevara C, Andelova M, Ciccarelli O, Wattjes MP, Ourselin S, Altmann DR, Tijms BM, Barkhof F, Toosy AT; MAGNIMS Study Group.

Mult Scler. 2019 Jul 24:1352458519865739. doi: 10.1177/1352458519865739. [Epub ahead of print]

6.

Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort.

Hacohen Y, Brownlee W, Mankad K, Chong WK', Thompson A, Lim M, Wassmer E, Hemingway C, Barkhof F, Ciccarelli O.

Mult Scler. 2019 Jul 18:1352458519863781. doi: 10.1177/1352458519863781. [Epub ahead of print]

PMID:
31317829
7.

High-dimensional detection of imaging response to treatment in multiple sclerosis.

Kanber B, Nachev P, Barkhof F, Calvi A, Cardoso J, Cortese R, Prados F, Sudre CH, Tur C, Ourselin S, Ciccarelli O.

NPJ Digit Med. 2019 Jun 10;2:49. doi: 10.1038/s41746-019-0127-8. eCollection 2019. Erratum in: NPJ Digit Med. 2019 Jul 16;2:66.

8.

Advances in brain imaging in multiple sclerosis.

Cortese R, Collorone S, Ciccarelli O, Toosy AT.

Ther Adv Neurol Disord. 2019 Jun 27;12:1756286419859722. doi: 10.1177/1756286419859722. eCollection 2019. Review.

9.

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA.

Brain. 2019 Jul 1;142(7):1858-1875. doi: 10.1093/brain/awz144.

10.

Lifespan normative data on rates of brain volume changes.

Battaglini M, Gentile G, Luchetti L, Giorgio A, Vrenken H, Barkhof F, Cover KS, Bakshi R, Chu R, Sormani MP, Enzinger C, Ropele S, Ciccarelli O, Wheeler-Kingshott C, Yiannakas M, Filippi M, Rocca MA, Preziosa P, Gallo A, Bisecco A, Palace J, Kong Y, Horakova D, Vaneckova M, Gasperini C, Ruggieri S, De Stefano N; MAGNIMS Study Group.

Neurobiol Aging. 2019 Sep;81:30-37. doi: 10.1016/j.neurobiolaging.2019.05.010. Epub 2019 May 22.

PMID:
31207467
11.

The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.

Lai Q, Vitale A, Iesari S, Finkenstedt A, Mennini G, Onali S, Hoppe-Lotichius M, Manzia TM, Nicolini D, Avolio AW, Mrzljak A, Kocman B, Agnes S, Vivarelli M, Tisone G, Otto G, Tsochatzis E, Rossi M, Viveiros A, Ciccarelli O, Cillo U, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group.

Liver Transpl. 2019 Jul;25(7):1023-1033. doi: 10.1002/lt.25492.

PMID:
31087772
12.

A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis.

Tur C, Grussu F, Prados F, Charalambous T, Collorone S, Kanber B, Cawley N, Altmann DR, Ourselin S, Barkhof F, Clayden JD, Toosy AT, Wheeler-Kingshott CAG, Ciccarelli O.

Mult Scler. 2019 May 10:1352458519845105. doi: 10.1177/1352458519845105. [Epub ahead of print]

PMID:
31074686
13.

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.

Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. doi: 10.1073/pnas.1818978116. Epub 2019 May 9.

14.

Advances in spinal cord imaging in multiple sclerosis.

Moccia M, Ruggieri S, Ianniello A, Toosy A, Pozzilli C, Ciccarelli O.

Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419840593. doi: 10.1177/1756286419840593. eCollection 2019. Review.

15.

Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.

Brownlee WJ, Solanky B, Prados F, Yiannakas M, Da Mota P, Riemer F, Cardoso MJ, Ourselin S, Golay X, Gandini Wheeler-Kingshott C, Ciccarelli O.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):755-760. doi: 10.1136/jnnp-2018-319634. Epub 2019 Apr 4.

PMID:
30948625
16.

Paediatric multiple sclerosis: a new era in diagnosis and treatment.

Duignan S, Brownlee W, Wassmer E, Hemingway C, Lim M, Ciccarelli O, Hacohen Y.

Dev Med Child Neurol. 2019 Sep;61(9):1039-1049. doi: 10.1111/dmcn.14212. Epub 2019 Apr 1. Review.

PMID:
30932181
17.

Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.

d'Ambrosio A, Valsasina P, Gallo A, De Stefano N, Pareto D, Barkhof F, Ciccarelli O, Enzinger C, Tedeschi G, Stromillo ML, Arévalo MJ, Hulst HE, Muhlert N, Koini M, Filippi M, Rocca MA.

Mult Scler. 2019 Mar 19:1352458519837707. doi: 10.1177/1352458519837707. [Epub ahead of print]

PMID:
30887862
18.

Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.

Iesari S, Inostroza Núñez ME, Rico Juri JM, Ciccarelli O, Bonaccorsi-Riani E, Coubeau L, Laterre PF, Goffette P, De Reyck C, Lengelé B, Gianello P, Lerut J.

Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):132-142. doi: 10.1016/j.hbpd.2019.02.007. Epub 2019 Feb 28.

PMID:
30850341
19.

Clinical relevance of cortical network dynamics in early primary progressive MS.

Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O.

Mult Scler. 2019 Feb 25:1352458519831400. doi: 10.1177/1352458519831400. [Epub ahead of print]

20.

Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis.

Rossor T, Benetou C, Wright S, Duignan S, Lascelles K, Robinson R, Das K, Ciccarelli O, Wassmer E, Hemingway C, Lim M, Hacohen Y.

Mult Scler. 2019 Feb 7:1352458518823486. doi: 10.1177/1352458518823486. [Epub ahead of print]

PMID:
30730236
21.

Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.

Eden D, Gros C, Badji A, Dupont SM, De Leener B, Maranzano J, Zhuoquiong R, Liu Y, Granberg T, Ouellette R, Stawiarz L, Hillert J, Talbott J, Bannier E, Kerbrat A, Edan G, Labauge P, Callot V, Pelletier J, Audoin B, Rasoanandrianina H, Brisset JC, Valsasina P, Rocca MA, Filippi M, Bakshi R, Tauhid S, Prados F, Yiannakas M, Kearney H, Ciccarelli O, Smith SA, Andrada Treaba C, Mainero C, Lefeuvre J, Reich DS, Nair G, Shepherd TM, Charlson E, Tachibana Y, Hori M, Kamiya K, Chougar L, Narayanan S, Cohen-Adad J.

Brain. 2019 Mar 1;142(3):633-646. doi: 10.1093/brain/awy352.

PMID:
30715195
22.

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.

Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

Lancet Neurol. 2019 Feb;18(2):185-197. doi: 10.1016/S1474-4422(18)30460-5. Review.

PMID:
30663608
23.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

24.

Multiple sclerosis in 2018: new therapies and biomarkers.

Ciccarelli O.

Lancet Neurol. 2019 Jan;18(1):10-12. doi: 10.1016/S1474-4422(18)30455-1. No abstract available.

PMID:
30563672
25.

Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration.

Ciccarelli O, Colson A, De Saeger C, Reding R, Sempoux C, Leclercq IA, Stärkel P.

Onco Targets Ther. 2018 Oct 17;11:7143-7153. doi: 10.2147/OTT.S176903. eCollection 2018.

26.

Tacrolimus and Single Intraoperative High-dose of Anti-T-lymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation: One-year Results of an Investigator-driven Randomized Controlled Trial.

Iesari S, Ackenine K, Foguenne M, De Reyck C, Komuta M, Bonaccorsi Riani E, Ciccarelli O, Coubeau L, Lai Q, Gianello P, Lerut J.

Ann Surg. 2018 Nov;268(5):776-783. doi: 10.1097/SLA.0000000000002943.

PMID:
30307410
27.

Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks.

Gros C, De Leener B, Badji A, Maranzano J, Eden D, Dupont SM, Talbott J, Zhuoquiong R, Liu Y, Granberg T, Ouellette R, Tachibana Y, Hori M, Kamiya K, Chougar L, Stawiarz L, Hillert J, Bannier E, Kerbrat A, Edan G, Labauge P, Callot V, Pelletier J, Audoin B, Rasoanandrianina H, Brisset JC, Valsasina P, Rocca MA, Filippi M, Bakshi R, Tauhid S, Prados F, Yiannakas M, Kearney H, Ciccarelli O, Smith S, Treaba CA, Mainero C, Lefeuvre J, Reich DS, Nair G, Auclair V, McLaren DG, Martin AR, Fehlings MG, Vahdat S, Khatibi A, Doyon J, Shepherd T, Charlson E, Narayanan S, Cohen-Adad J.

Neuroimage. 2019 Jan 1;184:901-915. doi: 10.1016/j.neuroimage.2018.09.081. Epub 2018 Oct 6.

PMID:
30300751
28.

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.

Melendez-Torres GJ, Armoiry X, Court R, Patterson J, Kan A, Auguste P, Madan J, Counsell C, Ciccarelli O, Clarke A.

BMC Neurol. 2018 Oct 3;18(1):162. doi: 10.1186/s12883-018-1162-9. Review.

29.

Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.

Brownlee WJ, Miszkiel KA, Tur C, Barkhof F, Miller DH, Ciccarelli O.

Neurology. 2018 Sep 18;91(12):e1130-e1134. doi: 10.1212/WNL.0000000000006207. Epub 2018 Aug 17.

30.

Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Yes.

Cortese R, Ciccarelli O.

Mult Scler. 2018 Oct;24(12):1536-1537. doi: 10.1177/1352458518778010. Epub 2018 Jul 23. No abstract available.

PMID:
30033804
31.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C, Eshaghi A, Altmann DR, Jenkins TM, Prados F, Grussu F, Charalambous T, Schmidt A, Ourselin S, Clayden JD, Wheeler-Kingshott CAMG, Thompson AJ, Ciccarelli O, Toosy AT.

Sci Rep. 2018 Jul 16;8(1):10715. doi: 10.1038/s41598-018-29017-1.

32.

Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.

Hagens MHJ, Burggraaff J, Kilsdonk ID, de Vos ML, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Ciccarelli O, Gasperini C, Lukas C, Wattjes MP, Barkhof F; MAGNIMS Study Group.

Neurology. 2018 Jul 17;91(3):e249-e257. doi: 10.1212/WNL.0000000000005825. Epub 2018 Jun 20.

33.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

34.

Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.

Eyre M, Hameed A, Wright S, Brownlee W, Ciccarelli O, Bowman R, Lim M, Wassmer E, Thompson D, Hemingway C, Hacohen Y.

Dev Med Child Neurol. 2018 Dec;60(12):1244-1250. doi: 10.1111/dmcn.13757. Epub 2018 Apr 11.

PMID:
29637998
35.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
36.

Multiple sclerosis.

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O.

Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23. Review.

PMID:
29576504
37.

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis.

Schoonheim MM, Ciccarelli O.

Neurology. 2018 Apr 10;90(15):677-678. doi: 10.1212/WNL.0000000000005279. Epub 2018 Mar 14. No abstract available.

PMID:
29540583
38.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
39.

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O.

Neurology. 2018 Apr 3;90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.

PMID:
29514948
40.

Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.

Duignan S, Wright S, Rossor T, Cazabon J, Gilmour K, Ciccarelli O, Wassmer E, Lim M, Hemingway C, Hacohen Y.

Dev Med Child Neurol. 2018 Sep;60(9):958-962. doi: 10.1111/dmcn.13703. Epub 2018 Feb 22.

41.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
42.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

43.

Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.

Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Wuerfel J, Ciccarelli O, Gasperini C, Lukas C, Rovira A, Barkhof F, Wattjes MP; MAGNIMS Study Group.

Mult Scler. 2019 Mar;25(3):352-360. doi: 10.1177/1352458517751647. Epub 2018 Jan 12.

44.

Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.

Tur C, Moccia M, Barkhof F, Chataway J, Sastre-Garriga J, Thompson AJ, Ciccarelli O.

Nat Rev Neurol. 2018 Feb;14(2):75-93. doi: 10.1038/nrneurol.2017.171. Epub 2018 Jan 12. Review.

PMID:
29326424
45.

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, Kalser J, Poulat AL, Maurey H, Ganelin-Cohen E, Wassmer E, Hemingway C, Forsyth R, Hennes EM, Leite MI, Ciccarelli O, Anlar B, Hintzen R, Marignier R, Palace J, Baumann M, Rostásy K, Neuteboom R, Deiva K, Lim M.

JAMA Neurol. 2018 Apr 1;75(4):478-487. doi: 10.1001/jamaneurol.2017.4601.

46.

'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.

Hacohen Y, Rossor T, Mankad K, Chong W', Lux A, Wassmer E, Lim M, Barkhof F, Ciccarelli O, Hemingway C.

Dev Med Child Neurol. 2018 Apr;60(4):417-423. doi: 10.1111/dmcn.13649. Epub 2017 Dec 30.

47.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
48.

Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria.

Svenningsson A, Ciccarelli O.

Neurology. 2017 Dec 5;89(23):2308-2309. doi: 10.1212/WNL.0000000000004725. Epub 2017 Nov 3. No abstract available.

PMID:
29101273
49.

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.

Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.

Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.

50.

Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.

Hacohen Y, Ciccarelli O, Hemingway C.

Brain. 2017 May 1;140(5):1172-1174. doi: 10.1093/brain/awx075. No abstract available.

PMID:
29050372

Supplemental Content

Loading ...
Support Center